1 / 5

Parallel Session 9 Contemporary Challenges in Statistical Evaluation of Diagnostic Products

Parallel Session 9 Contemporary Challenges in Statistical Evaluation of Diagnostic Products . Stuart Baker (NIH/NCI) Marina Kondratovich (FDA/CDRH) Ping Shi (Abbott Diagnostics). Chairs: Gene Pennello (CDRH) Lakshmi Vishnuvajjala (CDRH).

ratana
Download Presentation

Parallel Session 9 Contemporary Challenges in Statistical Evaluation of Diagnostic Products

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Parallel Session 9Contemporary Challenges in Statistical Evaluation of Diagnostic Products Stuart Baker (NIH/NCI)Marina Kondratovich (FDA/CDRH)Ping Shi (Abbott Diagnostics) Chairs: Gene Pennello (CDRH)Lakshmi Vishnuvajjala (CDRH)

  2. Session Description: This session is a sampling of some important statistical challenges that are present in the design and analysis of some diagnostic products. Speakers/Titles: "Classification rules for high-dimensional markers: searching for complementary marker pairs", Stuart Baker, NIH/NCI "Comparing the Diagnostic Accuracies of Two Tests in Studies with Verification Bias", Marina Kondratovich, FDA/CDRH "Computer Simulation in Medical Diagnostic Assay Calibration Evaluation", Ping Shi, PhD, Abbott Diagnostics

  3. Comparing Diagnostic Accuracies of Two Tests in the Studies with Verification Bias Marina Kondratovich, Ph.D. Division of Biostatistics, Center for Devices and Radiological Health, U.S. Food and Drug Administration. No official support or endorsement by the Food and Drug Administration of this presentation is intended or should be inferred. September, 2005

  4. Classification rules for high dimensional markers: searching for complementary marker pairs Stuart G. Baker, et al sb16i@nih.gov Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA 

  5. Computer Simulation in Medical Diagnostic Assay Calibration Evaluation Ping Shi Ph.D Abbott Laboratories Sept. 16, 2005

More Related